Where does Invox Belgium NV rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Invox Belgium NV ranks #35,958 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Invox Belgium NV hold?

Invox Belgium NV holds 7 US utility patents granted between 2024 and 2025, spanning 4 technology areas.

What is Invox Belgium NV's Innovation Score?

Invox Belgium NV has an Innovation Score of 43.3 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Invox Belgium NV's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Invox Belgium NV.

What does claim depth mean for Invox Belgium NV's patents?

Invox Belgium NV's patents average 15.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Invox Belgium NV patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Invox Belgium NV

Q: What technology areas does Invox Belgium NV focus on?

Invox Belgium NV's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 6 patents, ranking #1,115 of 3,490 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Invox ranks #35,958 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.

#35,958
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.3/100): 15.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R35958 · Foreign Corporation #35,958 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #35,958/49,997
PHOTO-FINISH Inventec Technology
CPC-NARROW A61M · 4 areas
INNOV-PAR 43.3/100
CLAIMS-RICH 15.1 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2024–2025 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Inventec Technology Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Invox’s 43.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (17%) Velocity 20.0 pts (46%) Breadth 7.1 pts (16%) Claim depth 9.1 pts (21%)

Qualcomm Incorporated · highest

85
Invox Belgium · this assignee

43
3D Lighting… · lowest

7

What this shows Invox's Innovation Score is 43.3/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Invox?

Each dot is one of Invox’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Invox’s own 15.1 claims/patent is ABOVE the 10.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Invox vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Invox's grants concentrate

Invox Belgium NV is a focused PatentsView assignee: 4 CPC subclasses with 85.7% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). By volume, Invox sits between Inventec Technology Corporation and IP Science Limited.

Invox's three-year grant acceleration

Invox Belgium NV shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Inventec Technolo…

7
Inventor-e

7
Investment Asset…

7
Invidx

7
Iogenetics

7
Ionic Solutions

7
Ioxt

7
IP Science

7
Invox Belgium ◀

7

What this shows Invox holds 7 patents at rank #35,862, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Invox

By rank, the assignees closest to #35,862 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Invox's primary technology class.

Invox's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table

Invox Belgium NV patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2024	3	42.9%
2025partial year	4	57.1%

Which technologies does Invox Belgium NV patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Invox Belgium NV's patent record in context - here's where to go next.

Invox Belgium NV's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 85.7% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #35,958 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Invox Belgium NV against Inventec Technology Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.